HepaTx, a preclinical-stage biotechnology company developing cell therapies for liver diseases, announced that Mazen Noureddin, MD, MHSc, a renowned expert in the field of hepatology, has joined the company’s Scientific Advisory Board.
March 7, 2023
· 2 min read